Dicerna, an RNAi drug startup based in Boston (see related story, this issue), has appointed Roberto Guerciolini as senior vice president of pharmaceutical development.
Guerciolini, who is also a co-founder of Dicerna, was previously the senior vice president of development and chief medical officer of Sirna Therapeutics.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
